Company: GMRE
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001104659-25-110926
Chunk: 7

Company: Global Medical REIT Inc.
Filing Date: 2025-11-13
Form: 424B5
Chunk 7
---
 address of the SEC’s website is www.sec.gov. We intend to apply to list the
Series B Preferred Stock on the New York Stock Exchange, or NYSE, under the symbol “GMRE PrB.” Our corporate website
is located at www.globalmedicalreit.com. Our internet website and the information contained therein or connected thereto do not
constitute a part of this prospectus supplement, the accompanying prospectus or any amendment or supplement thereto.

We have filed with the SEC a registration statement
on Form S-3 under the Securities Act with respect to the securities offered by this prospectus supplement and the accompanying prospectus.
This prospectus supplement and the accompanying prospectus, which form a part of the registration statement, do not contain all of the
information set forth in the registration statement and its exhibits and schedules, certain parts of which are omitted in accordance with
the SEC’s rules and regulations. For further information about us, our common stock and our Series B Preferred Stock,
we refer you to the registration statement and to such exhibits and schedules. Statements contained in this prospectus supplement and
the accompanying prospectus concerning the provisions of any document filed as an exhibit to the registration statement or otherwise filed
with the SEC are not necessarily complete, and in each instance reference is made to the copy of such document so filed. Each such statement
is qualified in its entirety by such reference.

<div align='center'>S-v

INCORPORATION BY REFERENCE OF INFORMATION FILED WITH THE SEC</div>

The SEC allows us to “incorporate by reference”
into this prospectus supplement and the accompanying prospectus the information we file with the SEC, which means that we can disclose
important business, financial and other information to you by referring you to other documents separately filed with the SEC. The information
incorporated by reference is considered to be part of this prospectus supplement and the accompanying prospectus from the date we file
that document. Any reports filed by us with the SEC after the date of this prospectus supplement and before the date that the offering
of the securities by means of this prospectus supplement and the accompanying prospectus is terminated will automatically update and,
where applicable, supersede any information contained in this prospectus supplement and the accompanying prospectus or incorporated by
reference in this prospectus supplement and the accompanying prospectus.

We incorporate by reference the following documents
or information filed with the SEC into this prospectus supplement and the accompanying prospectus (other than, in each case,